Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

C4 THERAPEUTICS, INC.

(CCCC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 1 4261 748--
Entreprise Value (EV)1 1 0641 3701 4621 435
P/E ratio -21,5x-17,4x-15,2x-12,9x
Yield ----
Capitalization / Revenue 42,9x53,0x57,1x67,2x
EV / Revenue 32,1x41,5x47,8x55,1x
EV / EBITDA -19,2x-15,6x-12,6x-11,6x
Price to Book 5,08x4,77x6,60x5,29x
Nbr of stocks (in thousands) 43 03048 626--
Reference price (USD) 33,136,736,736,7
Announcement Date 03/11/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 21,433,233,030,626,0
EBITDA1 --55,4-87,8-116-124
Operating profit (EBIT)1 --60,4-95,0-122-154
Operating Margin --182%-288%-398%-591%
Pre-Tax Profit (EBT)1 --67,0-97,9-121-159
Net income1 --66,3-96,9-126-159
Net margin --200%-294%-412%-612%
EPS2 -3,67-1,54-2,11-2,41-2,85
Dividend per Share2 -----
Announcement Date 09/10/202003/11/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 7,439,788,507,24
EBITDA1 --21,6-23,9-22,1
Operating profit (EBIT)1 -20,5-22,1-24,3-27,6
Operating Margin -276%-226%-285%-381%
Pre-Tax Profit (EBT)1 ---24,7-29,6
Net income1 --22,6-24,7-28,3
Net margin --231%-290%-391%
EPS2 -0,49-0,51-0,51-0,59
Dividend per Share ----
Announcement Date 05/13/202108/11/202111/10/2021-
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 -362378286313
Leverage (Debt / EBITDA) -6,53x4,31x2,47x2,53x
Free Cash Flow1 --67,9-72,4-113-58,1
ROE (Net Profit / Equities) ---24,3%-36,3%-59,0%
Shareholders' equity1 --399347270
ROA (Net Profit / Asset) ---19,9%-29,6%-48,6%
Assets1 --487426328
Book Value Per Share2 -6,527,685,566,93
Cash Flow per Share2 ---1,61-1,95-2,25
Capex1 -0,653,652,813,08
Capex / Sales -1,96%11,1%9,18%11,8%
Announcement Date 09/10/202003/11/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 1 748 090 607
Net sales (USD) 33 195 000
Number of employees 99
Sales / Employee (USD) 335 303
Free-Float 87,4%
Free-Float capitalization (USD) 1 527 061 056
Avg. Exchange 20 sessions (USD) 8 050 668
Average Daily Capital Traded 0,46%
EPS & Dividend